CEbiotech.com - Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular
searches

All articles

Filters:
Show search box
2013-10-01
H3 Biomedicine and Selvita Announce Strategic Collaboration to Develop Precision Cancer Med

H3 Biomedicine and Selvita Announce Strategic Collaboration to Develop Precision Cancer Medicines

H3 Biomedicine Inc., a biopharmaceutical company specializing in the discovery and development of precision oncology treatments, and Selvita (PL: SLV), one of the largest drug discovery companies in Eastern Europe, announced today that they have entered into a strategic collaboration to develop break... Read more
Tags Selvita , H3 Biomedicine